Moreover, Diaz-Blanco E. et al. suggested the expression of GAS2 was higher in CD34+ cells from CML patients in CP compared to that from normal bone marrow (NBM) using microarray. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.